TickerFacts.

Cell Source, Inc. (CLCS): Total Liabilities

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$18.82M
As of 2024-12-31
$20.43M
As of 2025-03-31
+22.9%
3-year compound annual growth
+26.3%
5-year compound annual growth
2014-12-31: $3.91M2015-12-31: $5.97M2016-12-31: $6.45M2017-12-31: $5.09M2018-12-31: $4.99M2019-12-31: $5.86M2020-12-31: $8.40M2021-12-31: $10.14M2022-12-31: $13.04M2023-12-31: $15.81M2024-12-31: $18.82M$18.82M
2014-12-31 Total Liabilities (USD) 2024-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2024-12-31$18.82M+19.1%2026-04-07, Balance as of period end
2023-12-31$15.81M+21.2%2026-04-07, Balance as of period end
2022-12-31$13.04M+28.6%2024-06-24, Balance as of period end
2021-12-31$10.14M+20.7%2023-08-08, Balance as of period end
2020-12-31$8.40M+43.4%2021-04-15, Balance as of period end
2019-12-31$5.86M+17.5%2021-04-15, Balance as of period end
2018-12-31$4.99M-2.0%2020-03-30, Balance as of period end
2017-12-31$5.09M-21.1%2019-04-01, Balance as of period end
2016-12-31$6.45M+8.1%2018-07-25, Balance as of period end
2015-12-31$5.97Mn/c2018-07-25, Balance as of period end
2014-12-31$3.91Mn/a2016-04-14, Balance as of period end